Fecal Carriage Rate of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Among Apparently Health Food Handlers in Dilla University Student Cafeteria

References

• Chiu C-W, Li M-C, Ko W-C, et al. Clinical impact of gram-negative non fermenters on adults with community-onset bacteremia in the emergency department. J Microbiol Immunol Infect. 2015;48(1):92–100. doi:10.1016/j.jmii.2013.08.00424060496
   PubMedGoogle Scholar
• Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. Pharm Ther. 2015;40(4):277.
   Google Scholar
• Gelband H, Molly Miller P, Pant S, et al. The state of the world’s antibiotics 2015. Wound Heal S Afr. 2015;8(2):30–34.
   Google Scholar
• de La Blanchardière A, Dargère S, Guérin F, et al. Non-carbapenem therapy of urinary tract infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae. Med Mal Infect. 2015;45(5):169–172. doi:10.1016/j.medmal.2015.03.00325845927
   PubMed Web of Science ®Google Scholar
• Health U, Services H. Antibiotic resistance threats in the United States, 2013. Center Dis Control Prev. 2013;1–113.
   Google Scholar
• Kakati B, Agarwal S, Gupta S. Emerging issues regarding management of MDR non-fermenting gram negative ventilator associated pneumonia in a rural catering tertiary care hospital. J Med Sci Clin Res. 2015;4(10):13232–13238. doi:10.18535/jmscr/v4i10.69
   Google Scholar
• Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17(10):1791. doi:10.3201/eid1710.11065522000347
   PubMed Web of Science ®Google Scholar
• Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Infect Control. 2006;34(5):S20–S8. doi:10.1016/j.ajic.2006.05.23816813978
   PubMed Web of Science ®Google Scholar
• Dogan A, Lasch P, Neuschl C, et al. ATR-FTIR spectroscopy reveals genomic loci regulating the tissue response in high fat diet fed BXD recombinant inbred mouse strains. BMC Genom. 2013;14(1):386.
   Web of Science ®Google Scholar
• Aiken AM, Mturi N, Njuguna P, et al. Risk and causes of paediatric hospital-acquired bacteraemia in Kilifi District Hospital, Kenya: a prospective cohort study. Lancet. 2011;378(9808):2021–2027. doi:10.1016/S0140-6736(11)61622-X22133536
   PubMed Web of Science ®Google Scholar
• Abdallah H, Wintermans B, Reuland E, et al. Extended-spectrum β-lactamase-and carbapenemase-producing Enterobacteriaceae isolated from Egyptian patients with suspected blood stream infection. PLoS One. 2015;10(5).
   Web of Science ®Google Scholar
• McDonald M, Blondeau JM. Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones. J Cataract Refract Surg. 2010;36(9):1588–1598. doi:10.1016/j.jcrs.2010.06.02820692574
   PubMed Web of Science ®Google Scholar
• Organization WH. Antimicrobial Resistance: Global Report on Surveillance. World Health Organization; 2014.
   Google Scholar
• Duthey B. Priority Medicines for Europe and the World” a Public Health Approach to Innovation. WHO Background paper; 2013:6.
   Google Scholar
• Fournier PE, Richet H, Weinstein RA. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 2006;42(5):692–699. doi:10.1086/50020216447117
   PubMed Web of Science ®Google Scholar
• Bassetti M, Ginocchio F, Mikulska M. New treatment options against gram-negative organisms In: Annual Update in Intensive Care and Emergency Medicine 2011. Springer; 2011:501–515.
   Google Scholar
• Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657–686. doi:10.1128/CMR.18.4.657-686.200516223952
   PubMed Web of Science ®Google Scholar
• Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8(3):159–166. doi:10.1016/S1473-3099(08)70041-018291338
   PubMed Web of Science ®Google Scholar
• Alvarez-Uria G, Gandra S, Mandal S, Laxminarayan R. Global forecast of antimicrobial resistance in invasive isolates of Escherichia coli and Klebsiella pneumoniae. Int J Infect Dis. 2018;68:50–53. doi:10.1016/j.ijid.2018.01.01129410253
   PubMed Web of Science ®Google Scholar
• Murray TS, Peaper DR. The contribution of extended-spectrum β-lactamases to multidrug-resistant infections in children. Curr Opin Pediatr. 2015;27(1):124–131. doi:10.1097/MOP.000000000000018225565574
   PubMed Web of Science ®Google Scholar
• Bevan ER, Jones AM, Hawkey PM. Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype. J Antimicrob Chemother. 2017;72(8):2145–2155. doi:10.1093/jac/dkx14628541467
   PubMed Web of Science ®Google Scholar
• Bush K, Jacoby GA. Updated functional classification of β-lactamases. Antimicrob Agents Chemother. 2010;54(3):969–976. doi:10.1128/AAC.01009-0919995920
   PubMed Web of Science ®Google Scholar
• Testing E. Data from the EUCAST MIC Distribution Website. European Committee on Antimicrobial Susceptibility Testing Data from the EUCAST MIC Distribution Website. 2016.
   Google Scholar
• Drieux L, Brossier F, Sougakoff W, Jarlier V. Phenotypic detection of extended‐spectrum β‐lactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect. 2008;14:90–103. doi:10.1111/j.1469-0691.2007.01846.x18154532
   PubMed Web of Science ®Google Scholar
• Adler A, Katz DE, Marchaim D. The continuing plague of extended-spectrum β-lactamase–producing Enterobacteriaceae infections. Infect Dis Clin. 2016;30(2):347–375.
   Web of Science ®Google Scholar
• Indernath S, Priyadharsini RI, Manikkanan M, Babu SV. Prevalence and Phenotypic Characterization of ESBL Producing E. Coli and Klebsiella Among the Fecal Isolates of Normal Population.
   Google Scholar
• Rao SP, Rama PS, Gurushanthappa V, Manipura R, Srinivasan K. Extended-spectrum beta-lactamases producing Escherichia coli and Klebsiella pneumoniae: a multi-centric study across Karnataka. J Lab Physicians. 2014;6(1):7. doi:10.4103/0974-2727.12908324696553
   PubMedGoogle Scholar
• Fam N, Leflon-Guibout V, Fouad S, et al. CTX-M-15-producing Escherichia coli clinical isolates in Cairo (Egypt), including isolates of clonal complex ST10 and clones ST131, ST73, and ST405 in both community and hospital settings. Microb Drug Resist. 2011;17(1):67–73. doi:10.1089/mdr.2010.006321128836
   PubMed Web of Science ®Google Scholar
• Nijssen S, Florijn A, Bonten M, Schmitz F, Verhoef J, Fluit A. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents. 2004;24(6):585–591. doi:10.1016/j.ijantimicag.2004.08.00815555882
   PubMed Web of Science ®Google Scholar
• Girlich D, Bouihat N, Poirel L, Benouda A, Nordmann P. High rate of faecal carriage of extended-spectrum β-lactamase and OXA-48 carbapenemase-producing Enterobacteriaceae at a university hospital in Morocco. Clin Microbiol Infect. 2014;20(4):350–354. doi:10.1111/1469-0691.1232523927757
   PubMed Web of Science ®Google Scholar
• Moyo SJ, Aboud S, Kasubi M, Lyamuya EF, Maselle SY. Antimicrobial resistance among producers and non-producers of extended spectrum beta-lactamases in urinary isolates at a tertiary hospital in Tanzania. BMC Res Notes. 2010;3(1):348. doi:10.1186/1756-0500-3-34821184671
   PubMedGoogle Scholar
• Ogefere HO, Aigbiremwen PA, Omoregie R. Extended-spectrum beta-lactamase (ESBL)–producing gram-negative isolates from urine and wound specimens in a tertiary health facility in southern Nigeria. Trop J Pharm Res. 2015;14(6):1089–1094. doi:10.4314/tjpr.v14i6.22
   Web of Science ®Google Scholar
• Ouedraogo A-S, Sanou M, Kissou A, et al. High prevalence of extended-spectrum ß-lactamase producing Enterobacteriaceae among clinical isolates in Burkina Faso. BMC Infect Dis. 2016;16(1):326.27400864
   PubMed Web of Science ®Google Scholar
• Obeng-Nkrumah N, Twum-Danso K, Krogfelt KA, Newman MJ. High levels of extended-spectrum beta-lactamases in a major teaching hospital in Ghana: the need for regular monitoring and evaluation of antibiotic resistance. Am J Trop Med Hyg. 2013;89(5):960–964.24043693
   PubMed Web of Science ®Google Scholar
• Alfola MMHR, Kamel Z, Nada MGED, Rashed LA, El-Awady BA. Phenotypic and genotypic characterization of ESBL-producing Escherichia coli and Klebsiella pneumonia isolates from patient’s urine specimens. Int Arab J Antimicrob Agents. 2017;6(4).
   Google Scholar
• Kateregga JN, Kantume R, Atuhaire C, Lubowa MN, Ndukui JG. Phenotypic expression and prevalence of ESBL-producing Enterobacteriaceae in samples collected from patients in various wards of Mulago Hospital, Uganda. BMC Pharmacol Toxicol. 2015;16(1):14. doi:10.1186/s40360-015-0013-126031914
   PubMed Web of Science ®Google Scholar
• Sanneh B, Kebbeh A, Jallow HS, et al. Prevalence and risk factors for faecal carriage of extended spectrum β-lactamase producing Enterobacteriaceae among food handlers in lower basic schools in West Coast Region of The Gambia. PLoS One. 2018;13(8):e0200894. doi:10.1371/journal.pone.020089430102698
   PubMed Web of Science ®Google Scholar
• Abera B, Kibret M, Mulu W, Kirk M. Extended-spectrum beta (β)-lactamases and antibiogram in Enterobacteriaceae from clinical and drinking water sources from Bahir Dar City, Ethiopia. PLoS One. 2016;11(11):e0166519. doi:10.1371/journal.pone.016651927846254
   PubMed Web of Science ®Google Scholar
• Calbo E, Romaní V, Xercavins M, et al. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamases. J Antimicrob Chemother. 2006;57(4):780–783. doi:10.1093/jac/dkl03516492721
   PubMed Web of Science ®Google Scholar
• Briongos‐Figuero L, Gómez‐Traveso T, Bachiller‐Luque P, et al. Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended‐spectrum beta‐lactamase (ESBL)‐producing enterobacteria. Int J Clin Pract. 2012;66(9):891–896. doi:10.1111/j.1742-1241.2012.02991.x22897466
   PubMed Web of Science ®Google Scholar
• Okomo UA. Neonatal Infections; a Hospital-Based Study in the Gambia Examining Aetiology and Associated Maternal Colonisation. London School of Hygiene & Tropical Medicine; 2018.
   Google Scholar
• Alyamani EJ, Khiyami AM, Booq RY, Majrashi MA, Bahwerth FS, Rechkina E. The occurrence of ESBL-producing Escherichia coli carrying aminoglycoside resistance genes in urinary tract infections in Saudi Arabia. Ann Clin Microbiol Antimicrob. 2017;16(1):1. doi:10.1186/s12941-016-0177-628061852
   PubMed Web of Science ®Google Scholar
• Schwaber MJ, Navon-Venezia S, Schwartz D, Carmeli Y. High levels of antimicrobial coresistance among extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2005;49(5):2137–2139. doi:10.1128/AAC.49.5.2137-2139.200515855548
   PubMed Web of Science ®Google Scholar
• Esiobu N, Armenta L, Ike J. Antibiotic resistance in soil and water environments. Int J Environ Health Res. 2002;12(2):133–144.12396530
   PubMed Web of Science ®Google Scholar
• Leski TA, Taitt CR, Bangura U, et al. High prevalence of multidrug resistant Enterobacteriaceae isolated from outpatient urine samples but not the hospital environment in Bo, Sierra Leone. BMC Infect Dis. 2016;16(1):167. doi:10.1186/s12879-016-1495-127090787
   PubMed Web of Science ®Google Scholar
• Dagher C, Salloum T, Alousi S, Arabaghian H, Araj GF, Tokajian S. Molecular characterization of carbapenem resistant Escherichia coli recovered from a tertiary hospital in Lebanon. PLoS One. 2018;13(9):e0203323. doi:10.1371/journal.pone.020332330188911
   PubMed Web of Science ®Google Scholar
• Moges F, Setegn Eshetie WA, Mekonnen F, et al. High prevalence of extended-spectrum beta-lactamase-producing gram-negative pathogens from patients attending Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Amhara region. PLoS One. 2019;14(4):e0215177. doi:10.1371/journal.pone.021517730986262
   PubMed Web of Science ®Google Scholar
• Arabaghian H, Salloum T, Alousi S, Panossian B, Araj GF, Tokajian S. Molecular characterization of carbapenem resistant Klebsiella pneumoniae and Klebsiella quasipneumoniae isolated from Lebanon. Sci Rep. 2019;9(1):1–12. doi:10.1038/s41598-018-36554-230626917
   PubMed Web of Science ®Google Scholar
• Hamdani SS, Bhat BA, Tariq L, et al. Antibiotic resistance: the future disaster. Int J Res Appl Sci Biotechnol. 2020;7(4):133–145. doi:10.31033/ijrasb.7.4.16
   Google Scholar